“Shares of Dexcom tumbled almost 40% in extended trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. Here’s how the company did: Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a… Continue Reading…